Kevin Jong, MD
Ophthalmology · Houston, TXNPI 1124013214
Payments from drug & device makers
Across 1,880 payments — averaging $659.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon Research LLC$1.1M
- Bausch Health US, LLC$104K
- Bausch & Lomb Americas Inc.$40K
- Shire North American Group Inc$8K
- Amneal Pharmaceuticals LLC$7K
- AbbVie$4K
- plus $10K from 24 others
Across 6 payments — averaging $23,393 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$140K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon Research LLC | 1,469 | $1,067,473 |
| Bausch Health US, LLC | 5 | $104,251 |
| Bausch & Lomb Americas Inc. | 51 | $40,443 |
| Shire North American Group Inc | 5 | $8,469 |
| Amneal Pharmaceuticals LLC | 2 | $6,564 |
| AbbVie(2 entities) | 129 | $3,585 |
| Alcon | 49 | $2,031 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $1,832 |
| Johnson & Johnson Surgical Vision, Inc. | 4 | $1,405 |
| Tarsus Pharmaceuticals, Inc. | 27 | $772 |
| Novartis | 33 | $698 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 20 | $611 |
| Aerie Pharmaceuticals, Inc. | 11 | $517 |
| Sun Pharmaceutical Industries Inc. | 22 | $415 |
| Eyevance Pharmaceuticals LLC | 18 | $361 |
| Glaukos Corporation | 5 | $358 |
| Rxsight Inc | 2 | $142 |
| Thea Pharma Inc. | 5 | $125 |
| Oyster Point Pharma, Inc. | 5 | $124 |
| Carl Zeiss Meditec USA, Inc. | 3 | $121 |
| Sight Sciences, Inc. | 3 | $69 |
| Harrow Eye, LLC | 2 | $61 |
| Kala Pharmaceuticals, Inc. | 2 | $39 |
| Dompe US, Inc. | 1 | $29 |
| Mallinckrodt Enterprises LLC | 1 | $23 |
| NEW World Medical,inc. | 1 | $18 |
| Amgen | 1 | $17 |
| Ocular Therapeutix, Inc. | 1 | $17 |
| Carl Zeiss Meditec, Inc. | 1 | $14 |
| Akorn, Inc. | 1 | $13 |
How this compares
$1,240,598 in reported general payments places this provider in the 95th percentile of 1,355 ophthalmology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Houston
- David BrownHouston$51.7M
- John MichelettiHouston$3.3M
- Michael CaplanHouston$1.4M
- Shaheen KavoussiHouston$1.3M
- Stephen SladeHouston$1.2M
- Rosa TangHouston$1.1M
- Zaina Al-MohtasebHouston$1.1M
- Fiaz ZamanHouston$1M
- Stephen PflugfelderHouston$788K
- Christina WengHouston$722K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.